drugset / Trial / NCT04602845
Remimazolam Tosilate Sedation and Midazolam Sedation in Dental Patients
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Remimazolam Tosilate is a new short-acting benzodiazepines used in sedation. It has the advantages of rapid metabolism, quick recovery without injection pain. This study aims to compared with Midazolam, study whether Remimazolam Tosilate can achieve the same sedation effect with lower side effects on sedation maintenance period, During the recovery period of anesthesia, can Remimazolam Tosilatebe more stable and rapid.
Timeline
- Start
- 2021-04-01
- Primary completion
- 2021-06-30
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Midazolam | Small molecule | 2.5 mg | Intravenous |
| Subject | Remimazolam | Small molecule | 3 mg | Intravenous |
| Background | Fentanyl | Other / unclassified | 50 ug | Intravenous |
| Background | Flurbiprofen | Small molecule | 50 mg | — |
Indications
No indication recorded.